Treatment with midostaurin and other FLT3 targeting inhibitors is associated with an increased risk of cardiovascular adverse events in patients who underwent allogeneic hematopoietic stem cell transplantation with FLT3-mutated AML
Annals of hematology（2023）
关键词
Allogeneic stem cell transplantation,Acute myeloid leukemia,Targeted FLT3 inhibitor therapy,Cardiac toxicities
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要